Current stock page

Catalysts

NVO Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

Score data as of Oct 21, 2026

NVO

Leader

Strong Relative Position

NeutralEdge 9/10
$39.06−$0.29 (−0.74%)

Latest quote

  • Momentum
    56
  • Value
    60
  • Quality
    91
  • Risk resilience
    51
  • Sentiment
    —
algovestiq.comScore data as of Oct 21, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
—

No upcoming reporting date is available yet.

AIQ Catalyst
AIQ 67/100

Momentum 56/100 and sentiment — before the next covered event.

Recent coverage
2 articles

Updated Oct 21, 2026 · Sentiment 10.13%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 56/100AIQ Edge 9/10 Strong Relative Position
Beat rate
100%
4 of 4 reported periods
Average surprise
+20.0%
Across covered historical reports
Latest result
+17.1%
Aug 5, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 4, 2026—$0.80——$11.22B—
Aug 5, 2026—$0.82$0.96+17.1%$10.89B$12.13B
May 6, 2026—$0.87$1.04+19.5%$10.86B$11.02B
Feb 3, 2026—$0.90$1.00+11.1%$12.13B$12.5B
Nov 5, 2025—$0.77$1.02+32.5%$11.94B$11.53B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
—
-
covered analysts
No rating distribution in this snapshot.
12-month analyst target
—
— versus current price
Based on available analyst observations. Targets are estimates, not predictions.
No analyst target path in this snapshot.
Low target
—
—
Average target
—
—
High target
—
—

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event date—

Upcoming earnings date not available yet.

Sentiment score—

News pressure around the setup.

Momentum score56

Where event reaction would show up first.

AIQ score67/100

Composite decision read before event confirmation.

Analyst context

Analyst targets and estimate revisions are not included in the current coverage.

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
1
Neutral
1
Negative
0
zacks.com · Oct 19, 2026

Is Trending Stock Novo Nordisk A/S (NVO) a Buy Now?

Recently, Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.

insidermonkey.com · Oct 16, 2026

Novo Nordisk’s Growth Story Is Under Pressure as Eli Lilly Gains Ground

Novo Nordisk S/A (NYSE:NVO)'s investment story has changed dramatically. The stock has declined by over 25% since the start of 2026. The selloff has changed the stock's valuation.

Open full news and sentiment

NVO Catalysts FAQ

What are the next catalysts for NVO stock?

NVO's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move NVO stock?

Upcoming events that could move NVO include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could NVO's next earnings report affect the stock?

NVO's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive NVO stock higher?

NVO could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt NVO stock?

NVO could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.